These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10812093)

  • 21. Prevention of chronic allograft rejection by Vitamin D receptor agonists.
    Adorini L; Amuchastegui S; Daniel KC
    Immunol Lett; 2005 Aug; 100(1):34-41. PubMed ID: 16054704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies.
    Reischig T
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):903-10. PubMed ID: 20695746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and treatment of antibody-mediated kidney allograft rejection.
    Böhmig G; Regele H
    Transpl Int; 2003 Nov; 16(11):773-87. PubMed ID: 14534774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rejection after kidney transplantation: new concepts, new therapeutic options.
    van der Woude FJ; Hollander AA
    Transplant Proc; 1998 Aug; 30(5):2419-24. PubMed ID: 9723523
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of dietary fish oils in renal allograft recipients with chronic vascular rejection.
    Sweny P
    Transplant Proc; 1993 Apr; 25(2):2089-91. PubMed ID: 8470281
    [No Abstract]   [Full Text] [Related]  

  • 26. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic rejection: pathogenesis and treatment.
    Lee HM
    Transplant Proc; 1996 Jun; 28(3):1146-7. PubMed ID: 8658602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of Personalized and Targeted Preventive Therapies for Chronic Lung Allograft Dysfunction Subtypes;A Novel Strategy].
    Saito T; Sato M; Taniguchi Y; Murakawa T; Keshavjee S
    Kyobu Geka; 2016 Oct; 69(11):931-934. PubMed ID: 27713199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
    Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
    J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of chronic allograft rejection.
    Joosten SA; van Kooten C; Paul LC
    Transpl Int; 2003 Mar; 16(3):137-45. PubMed ID: 12664207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A chronic large animal model of lung allograft rejection.
    Schmid RA; Kwong K; Boasquevisque CH; Wick M; Patterson GA; Sundt TM
    Transplant Proc; 1997; 29(1-2):1521. PubMed ID: 9123409
    [No Abstract]   [Full Text] [Related]  

  • 32. [Is tacrolimus effective for ongoing renal allograft rejection?].
    Nishioka T; Imanishi M; Akiyama T; Kurita T; Kokado Y; Takahara S; Ito K; Sagawa S; Higashi Y; Otomo Y; Hayashi T
    Hinyokika Kiyo; 1998 May; 44(5):369-72. PubMed ID: 9656112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
    Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic allograft rejection.
    Häyry P; Myllärniemi M; Aavik E
    Transplant Proc; 1996 Aug; 28(4):2337-8. PubMed ID: 8769244
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are there markers to initiate treatment of chronic rejection?
    Fellström B; Backman U; Larsson E; Wahlberg J; Zezina L
    Transplant Proc; 1999 Jun; 31(4):1796-8. PubMed ID: 10371956
    [No Abstract]   [Full Text] [Related]  

  • 37. 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation.
    Adorini L
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1458-63. PubMed ID: 12431018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunology insights into cardiac allograft rejection.
    Savasta M; Lentini S
    Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [50 Years ago: First Successful Treatment of Acute Allograft Rejection after a Human Heart Transplantation].
    Land WG
    Dtsch Med Wochenschr; 2018 Dec; 143(25):1864-1865. PubMed ID: 30562821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy.
    Serón D; Moreso F; Ramón JM; Hueso M; Condom E; Fulladosa X; Bover J; Gil-Vernet S; Castelao AM; Alsina J; Grinyó JM
    Transplantation; 2000 May; 69(9):1849-55. PubMed ID: 10830221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.